StonvexLoading…
StonvexCore line items from ALB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-07-28 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $1.58B | $1.43B | $5.14B | $3.71B | $2.41B |
Operating Income | Not available | $233.51M | $-367.08M | $-149.70M | $67.29M |
Net Income | Not available | $319.09M | $-510.63M | $-96.45M | $64.25M |
EPS (Diluted) | $3.06 | $2.34 | $-5.76 | $-1.88 | $-0.16 |
Total Assets | Not available | $15.14B | $16.37B | $17.15B | $17.29B |
Total Liabilities | Not available | Not available | Not available | Not available | Not available |
Cash & Equivalents | Not available | $1.09B | $1.62B | $1.93B | $1.81B |
Free Cash Flow OCF − CapEx | Not available | $247.57M | $692.47M | $459.37M | $235.93M |
Shares Outstanding | Not available | 117.89M | 117.72M | 117.69M | 117.67M |